Table II.
Summary of Tumor Prescription Coverage and Point Doses for Pre- and Post-implant MRI-based Isodose Plans
| V100 (%) | Dmin (Gy) | Apex Dose (Gy) | Base Dose (Gy) | Optic Disc (Gy) | Fovea (Gy) | Lens (Gy) | Prescription Depth (Gy) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient |
Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post |
| 1 | 100.0 | 57.3 | 89 | 45 | 74 | 56 | 221 | 117 | 61 | 34 | 93 | 38 | 9 | 9 | 86 | 86 |
| 2 | 100.0 | 100.0 | 117 | 86 | 106 | 88 | 438 | 314 | 50 | 37 | 64 | 47 | 44 | 45 | 90 | 90 |
| 3 | 100.0 | 98.1 | 118 | 77 | 103 | 75 | 428 | 252 | 75 | 65 | 96 | 78 | 16 | 13 | 84 | 84 |
| 4 | 100.0 | 97.2 | 95 | 73 | 92 | 86 | 224 | 184 | 92 | 63 | 50 | 38 | 16 | 15 | 86 | 85 |
| 5 | 99.8 | 80.9 | 83 | 56 | 84 | 71 | 465 | 341 | 167 | 94 | 172 | 89 | 34 | 36 | 85 | 85 |
| 6 | 100.0 | 100.0 | 117 | 110 | 106 | 100 | 554 | 433 | 26 | 27 | 20 | 20 | 62 | 49 | 83 | 84 |